← Leaderboards
Richard J Miller
University Of Chicago
$24,321,673
Attributed
$37,570,506
Total exposure
15
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,570,506 · 15
By mechanism
R01$20,697,631 · 6
UC2$10,654,454 · 1
R37$2,943,802 · 1
P30$1,340,890 · 2
P01$822,148 · 2
R61$797,674 · 1
Top collaborators
- Anne-Marie Malfait18 shared
- Martin K. Lotz4 shared
- Murali Prakriya4 shared
- Megumi Yamashita4 shared
- Leonidas C Platanias3 shared
- Gary E Schiltz3 shared
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsReceptorPainCellsChemokineBaseMediatingPathway InteractionsResponseSpinal GangliaAfferent NeuronsLabelSignal TransductionIn VivoJointsChemokine ReceptorCxcr4 ReceptorsKneeImageNociceptorsCxcr4 GenePatternPeripheral Nervous SystemSensory
Grant awards (74)
Mapping the joint-nerve interactome of the knee$3,853,422
UC2 · FY2025 · AR
Osteoarthritis Progression And Sensory Pathway Alterations$1,963,454
R01 · FY2025 · AR
Neurobiology Core C$251,638
P30 · FY2025 · AR · contact PI
Mapping the joint-nerve interactome of the knee$83,970
UC2 · FY2025 · AR
Neurobiology Core C$267,964
P30 · FY2024 · AR · contact PI
Precision Mapping of Knee Pain in Osteoarthritis: Understanding differences between pain with activity and rest$83,970
UC2 · FY2024 · AR
Osteoarthritis Progression And Sensory Pathway Alterations$654,131
R01 · FY2023 · AR
Neurobiology Core C$269,471
P30 · FY2023 · AR · contact PI
Mapping the joint-nerve interactome of the knee$6,633,092
UC2 · FY2022 · AR
Osteoarthritis Progression And Sensory Pathway Alterations$647,585
R01 · FY2022 · AR
Neurobiology Core C$272,440
P30 · FY2022 · AR · contact PI
Osteoarthritis Progression And Sensory Pathway Alterations$634,507
R01 · FY2021 · AR
Neurobiology Core C$279,377
P30 · FY2021 · AR · contact PI
Osteoarthritis Progression And Sensory Pathway Alterations$654,131
R01 · FY2020 · AR
Osteoarthritis Progression And Sensory Pathway Alterations$162,778
R01 · FY2020 · AR
Osteoarthritis Progression And Sensory Pathway Alterations$668,381
R01 · FY2019 · AR
The nervous joint: New concepts in the development of osteoarthritis$390,132
R61 · FY2019 · AR
The nervous joint: New concepts in the development of osteoarthritis$407,542
R61 · FY2018 · AR
Regulation of neural progenitor cell migration by store-operated CRAC channels$322,778
R01 · FY2018 · NS
Small molecule CXCR4 modulators as molecular probes for studying AML$513,581
R01 · FY2017 · CA
Osteoarthritis Progression and Sensory Pathway Alterations$426,722
R01 · FY2017 · AR
Regulation of neural progenitor cell migration by store-operated CRAC channels$322,778
R01 · FY2017 · NS
Small molecule CXCR4 modulators as molecular probes for studying AML$539,886
R01 · FY2016 · CA
Osteoarthritis Progression and Sensory Pathway Alterations$426,722
R01 · FY2016 · AR
Regulation of neural progenitor cell migration by store-operated CRAC channels$329,500
R01 · FY2016 · NS
Small molecule CXCR4 modulators as molecular probes for studying AML$529,121
R01 · FY2015 · CA
Osteoarthritis Progression and Sensory Pathway Alterations$433,800
R01 · FY2015 · AR
Chemokine Receptor Function in the Nervous System$373,695
R01 · FY2015 · DA · contact PI
Regulation of neural progenitor cell migration by store-operated CRAC channels$335,844
R01 · FY2015 · NS
Osteoarthritis Progression and Sensory Pathway Alterations$480,660
R01 · FY2014 · AR
Chemokine Receptor Function in the Nervous System$380,762
R01 · FY2014 · DA · contact PI
Osteoarthritis Progression And Sensory Pathway Alterations$483,198
R01 · FY2013 · AR
Chemokine Receptor Function in the Nervous System$366,897
R01 · FY2013 · DA · contact PI
Chemokine Receptor Function in the Nervous System$383,571
R01 · FY2012 · DA · contact PI
Chemokine Receptor Function in the Nervous System$447,690
R01 · FY2011 · DA · contact PI
HIV-1 Infection and the Peripheral Nervous System$367,342
R01 · FY2011 · NS · contact PI
HIV-1 Infection and the Peripheral Nervous System$371,043
R01 · FY2010 · NS · contact PI
Chemokine Receptor Function in the Nervous System$442,081
R01 · FY2009 · DA · contact PI
HIV-1 Infection and the Peripheral Nervous System$374,745
R01 · FY2009 · NS · contact PI
Chemokine Receptor Function in the Nervous System$345,189
R01 · FY2009 · DA · contact PI
Chemokine Receptor Function in the Nervous System$432,323
R01 · FY2008 · DA · contact PI
HIV-1 Infection and the Peripheral Nervous System$374,700
R01 · FY2008 · NS · contact PI
Interaction of Drugs with Neuronal Calcium Channels$403,622
R37 · FY2007 · MH · contact PI
HIV-1 Infection and the Peripheral Nervous System$366,498
R01 · FY2007 · NS · contact PI
Chemokine Receptor Function in the Nervous System$342,726
R01 · FY2007 · DA · contact PI
Chemokine Receptor Function in the Nervous System$45,354
R01 · FY2007 · DA · contact PI
Interaction of Drugs with Neuronal Calcium Channels$401,395
R37 · FY2006 · MH · contact PI
Chemokine Receptor Function in the Nervous System$343,150
R01 · FY2006 · DA · contact PI
HIV-1-Related Peripheral Sensory Neuropathy$335,235
R01 · FY2006 · NS · contact PI
Interaction of Drugs with Neuronal Calcium Channels$397,748
R37 · FY2005 · MH
Chemokine Receptor Function in the Nervous System$392,614
R01 · FY2005 · DA
HIV-1-Related Peripheral Sensory Neuropathy$344,099
R01 · FY2005 · NS
Interaction of Drugs with Neuronal Calcium Channels$385,576
R37 · FY2004 · MH
HIV-1-Related Peripheral Sensory Neuropathy$344,763
R01 · FY2004 · NS
CHEMOKINE RECEPTOR FUNCTION IN THE NERVOUS SYSTEM$331,660
R01 · FY2004 · DA
Interaction of Drugs with Neuronal Calcium Channels$374,386
R37 · FY2003 · MH
HIV-1-Related Peripheral Sensory Neuropathy$345,501
R01 · FY2003 · NS
CHEMOKINE RECEPTOR FUNCTION IN THE NERVOUS SYSTEM$322,971
R01 · FY2003 · DA
INTERACTION OF DRUGS WITH NEURONAL CALCIUM CHANNELS$346,859
R37 · FY2002 · MH
HIV-1-Related Peripheral Sensory Neuropathy$346,521
R01 · FY2002 · NS
CHEMOKINE RECEPTOR FUNCTION IN THE NERVOUS SYSTEM$311,843
R01 · FY2002 · DA
NOTCH SIGNALING IN MAMMALIAN NEUROGENESIS$308,704
R01 · FY2002 · NS
INTRACELLULAR CALCIUM AS A MEDIATOR OF BETA CELL SIGNALING AND INJURY$146,667
P01 · FY2002 · DK
INTERACTION OF DRUGS WITH NEURONAL CALCIUM CHANNELS$339,337
R37 · FY2001 · MH
CHEMOKINE RECEPTOR FUNCTION IN THE NERVOUS SYSTEM$301,492
R01 · FY2001 · DA
NOTCH SIGNALING IN MAMMALIAN NEUROGENESIS$301,175
R01 · FY2001 · NS
PROPERTIES AND REGULATION OF ALPHA 1E, A NOVEL NEURONAL CA2+ CHANNEL$159,403
P01 · FY2001 · NS
INTRACELLULAR CALCIUM AS A MEDIATOR OF BETA CELL SIGNALING AND INJURY$146,667
P01 · FY2001 · DK
CHEMOKINE RECEPTOR FUNCTION IN THE NERVOUS SYSTEM$423,730
R01 · FY2000 · DA
INTERACTION OF DRUGS WITH NEURONAL CALCIUM CHANNELS$294,879
R37 · FY2000 · MH
INTRACELLULAR CALCIUM AS A MEDIATOR OF BETA CELL SIGNALING AND INJURY$219,493
P01 · FY2000 · DK
PHARMACOLOGICAL SCIENCES TRAINING PROGRAM$197,170
T32 · FY2000 · GM
PROPERTIES AND REGULATION OF ALPHA 1E, A NOVEL NEURONAL CA2+ CHANNEL$149,918
P01 · FY2000 · NS
CELLULAR MECHANISM OF OPIATE ACTION$116,737
K05 · FY2000 · DA